Drosophila notal bristle as a novel assessment tool for pathogenic study of Tau toxicity and screening of therapeutic compounds

Po An Yeh, Ju Yi Chien, Chih Chung Chou, Yu Fen Huang, Chiou Yang Tang, Hsiang Yu Wang, Ming-Tsan Su

研究成果: 雜誌貢獻文章

16 引文 (Scopus)

摘要

To elucidate the Tau gain-of-toxicity functional mechanism and to search for potential treatments, we overexpressed human Tau variants (hTau) in the dorsal mesothorax (notum) of Drosophila. Overexpression of Tau variants caused loss of notal bristles, and the phenotype was used for evaluating toxicity of ectopic Tau. The bristle loss phenotype was found to be highly associated with the toxicity of hyperphosphoryled Tau in flies. We have shown that the bristle loss phenotype can be rescued either by reducing Glycogen synthase kinase 3β (GSK3β)/Shaggy (Sgg) activity or overexpressing Bβ2 regulatory subunits of PP2A. Elevated expression of the Drosophila Bβ2 homolog, Twins (Tws), also alleviated neuritic dystrophy of the dorsal arborization (da) neuron caused by Tau aggregation. Additionally, lowering endogenous Tau dosage was beneficial as it ameliorated the bristle loss phenotype. Finally, the bristle loss phenotype was used to evaluate the efficacy of potential therapeutic compounds. The GSK3β inhibitor, alsterpaullone, was found to suppress toxicity of Tau in a concentration-dependent manner. The notum of Drosophila, thus, provides a new tool and insights into Tau-induced toxicity. It could also potentially assist in screening new drugs for possible therapeutic intervention.

原文英語
頁(從 - 到)510-516
頁數7
期刊Biochemical and Biophysical Research Communications
391
發行號1
DOIs
出版狀態已發佈 - 2010 一月 1

指紋

Drosophila
Toxicity
Screening
Phenotype
Glycogen Synthase Kinase 3
Therapeutics
Preclinical Drug Evaluations
Diptera
Neurons
Agglomeration
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

引用此文

Drosophila notal bristle as a novel assessment tool for pathogenic study of Tau toxicity and screening of therapeutic compounds. / Yeh, Po An; Chien, Ju Yi; Chou, Chih Chung; Huang, Yu Fen; Tang, Chiou Yang; Wang, Hsiang Yu; Su, Ming-Tsan.

於: Biochemical and Biophysical Research Communications, 卷 391, 編號 1, 01.01.2010, p. 510-516.

研究成果: 雜誌貢獻文章

Yeh, Po An ; Chien, Ju Yi ; Chou, Chih Chung ; Huang, Yu Fen ; Tang, Chiou Yang ; Wang, Hsiang Yu ; Su, Ming-Tsan. / Drosophila notal bristle as a novel assessment tool for pathogenic study of Tau toxicity and screening of therapeutic compounds. 於: Biochemical and Biophysical Research Communications. 2010 ; 卷 391, 編號 1. 頁 510-516.
@article{eeaa64c27b8843fcbf1d6b4098990dd0,
title = "Drosophila notal bristle as a novel assessment tool for pathogenic study of Tau toxicity and screening of therapeutic compounds",
abstract = "To elucidate the Tau gain-of-toxicity functional mechanism and to search for potential treatments, we overexpressed human Tau variants (hTau) in the dorsal mesothorax (notum) of Drosophila. Overexpression of Tau variants caused loss of notal bristles, and the phenotype was used for evaluating toxicity of ectopic Tau. The bristle loss phenotype was found to be highly associated with the toxicity of hyperphosphoryled Tau in flies. We have shown that the bristle loss phenotype can be rescued either by reducing Glycogen synthase kinase 3β (GSK3β)/Shaggy (Sgg) activity or overexpressing Bβ2 regulatory subunits of PP2A. Elevated expression of the Drosophila Bβ2 homolog, Twins (Tws), also alleviated neuritic dystrophy of the dorsal arborization (da) neuron caused by Tau aggregation. Additionally, lowering endogenous Tau dosage was beneficial as it ameliorated the bristle loss phenotype. Finally, the bristle loss phenotype was used to evaluate the efficacy of potential therapeutic compounds. The GSK3β inhibitor, alsterpaullone, was found to suppress toxicity of Tau in a concentration-dependent manner. The notum of Drosophila, thus, provides a new tool and insights into Tau-induced toxicity. It could also potentially assist in screening new drugs for possible therapeutic intervention.",
keywords = "Alsterpaullone, Notum, PP2A, Tauopathy",
author = "Yeh, {Po An} and Chien, {Ju Yi} and Chou, {Chih Chung} and Huang, {Yu Fen} and Tang, {Chiou Yang} and Wang, {Hsiang Yu} and Ming-Tsan Su",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/j.bbrc.2009.11.089",
language = "English",
volume = "391",
pages = "510--516",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Drosophila notal bristle as a novel assessment tool for pathogenic study of Tau toxicity and screening of therapeutic compounds

AU - Yeh, Po An

AU - Chien, Ju Yi

AU - Chou, Chih Chung

AU - Huang, Yu Fen

AU - Tang, Chiou Yang

AU - Wang, Hsiang Yu

AU - Su, Ming-Tsan

PY - 2010/1/1

Y1 - 2010/1/1

N2 - To elucidate the Tau gain-of-toxicity functional mechanism and to search for potential treatments, we overexpressed human Tau variants (hTau) in the dorsal mesothorax (notum) of Drosophila. Overexpression of Tau variants caused loss of notal bristles, and the phenotype was used for evaluating toxicity of ectopic Tau. The bristle loss phenotype was found to be highly associated with the toxicity of hyperphosphoryled Tau in flies. We have shown that the bristle loss phenotype can be rescued either by reducing Glycogen synthase kinase 3β (GSK3β)/Shaggy (Sgg) activity or overexpressing Bβ2 regulatory subunits of PP2A. Elevated expression of the Drosophila Bβ2 homolog, Twins (Tws), also alleviated neuritic dystrophy of the dorsal arborization (da) neuron caused by Tau aggregation. Additionally, lowering endogenous Tau dosage was beneficial as it ameliorated the bristle loss phenotype. Finally, the bristle loss phenotype was used to evaluate the efficacy of potential therapeutic compounds. The GSK3β inhibitor, alsterpaullone, was found to suppress toxicity of Tau in a concentration-dependent manner. The notum of Drosophila, thus, provides a new tool and insights into Tau-induced toxicity. It could also potentially assist in screening new drugs for possible therapeutic intervention.

AB - To elucidate the Tau gain-of-toxicity functional mechanism and to search for potential treatments, we overexpressed human Tau variants (hTau) in the dorsal mesothorax (notum) of Drosophila. Overexpression of Tau variants caused loss of notal bristles, and the phenotype was used for evaluating toxicity of ectopic Tau. The bristle loss phenotype was found to be highly associated with the toxicity of hyperphosphoryled Tau in flies. We have shown that the bristle loss phenotype can be rescued either by reducing Glycogen synthase kinase 3β (GSK3β)/Shaggy (Sgg) activity or overexpressing Bβ2 regulatory subunits of PP2A. Elevated expression of the Drosophila Bβ2 homolog, Twins (Tws), also alleviated neuritic dystrophy of the dorsal arborization (da) neuron caused by Tau aggregation. Additionally, lowering endogenous Tau dosage was beneficial as it ameliorated the bristle loss phenotype. Finally, the bristle loss phenotype was used to evaluate the efficacy of potential therapeutic compounds. The GSK3β inhibitor, alsterpaullone, was found to suppress toxicity of Tau in a concentration-dependent manner. The notum of Drosophila, thus, provides a new tool and insights into Tau-induced toxicity. It could also potentially assist in screening new drugs for possible therapeutic intervention.

KW - Alsterpaullone

KW - Notum

KW - PP2A

KW - Tauopathy

UR - http://www.scopus.com/inward/record.url?scp=72949116144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72949116144&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2009.11.089

DO - 10.1016/j.bbrc.2009.11.089

M3 - Article

C2 - 19931224

AN - SCOPUS:72949116144

VL - 391

SP - 510

EP - 516

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -